Seeing Is Believing
CALT is currently covered by 1 analysts with an average potential upside of $21.72 (107.09%) backed by displayed 0 price targets and 2 ratings.
Analysts average stock forecasts to be materialized ratio is 44.44% with an average time for these price targets to be met of 40.67 days.
Highest price target for CALT is 20, Lowest price target is 16, average price target is 18.
Most recent stock forecast was given by VAMIL DIVAN from GUGGENHEIM on 18-Aug-2023. First documented stock forecast 17-Dec-2021.
Currently, out of the existing stock ratings of CALT - 2 which are a Hold (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
18
$-0.26 (-1.42%)
18
3 months 11 days ago
2/2 (100%)
$0.05 (1.04%)
21
Buy
74
$56.54 (323.83%)
79
6 months 12 days ago
0/4 (0%)
$58.26 (296.50%)
Buy
42
$26.51 (171.14%)
38
2 years 9 months 11 days ago
1/3 (33.33%)
$6.85 (23.74%)
101
What is CALT (Calliditas Therapeutics AB Sponsored ADR) average time for price targets to be met?
Which analyst has the current highest performing score on CALT (Calliditas Therapeutics AB Sponsored ADR) with a proven track record?
Which analyst has the current lower performing score on CALT (Calliditas Therapeutics AB Sponsored ADR) with a proven track record?
Which analyst has the most public recommendations on CALT (Calliditas Therapeutics AB Sponsored ADR)?
Which analyst is the currently most bullish on CALT (Calliditas Therapeutics AB Sponsored ADR)?
Which analyst is the currently most reserved on CALT (Calliditas Therapeutics AB Sponsored ADR)?